Patents by Inventor Thomas P. Hedman

Thomas P. Hedman has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20260061143
    Abstract: A method, kits, and devices for performing the method of immediately improving and/or restoring the mechanical integrity and material properties of thermally shrunk collagenous tissue through delivery of a non-toxic protein crosslinker to the tissue. A thermal energy device shrinks the target tissue using controlled application of thermal energy. A non-toxic protein crosslinker is injected and/or topically applied to the target tissue before, during, and/or after thermal shrinkage. A dual applicator may comprise a thermal energy probe and injection needle. The thermal energy probe may apply thermal energy to the target tissue and the injection needle may apply the non-toxic protein crosslinker to the target tissue. A kit for use in performing the method may provide various components used for applying thermal energy and applying the non-toxic protein crosslinker to the target tissue.
    Type: Application
    Filed: August 27, 2025
    Publication date: March 5, 2026
    Inventors: Thomas P. Hedman, Adam Rogers, John Goebel
  • Publication number: 20250090343
    Abstract: An intradiscal shield and an exterior shield configured to prevent re-herniation and to provide structural integrity to a spinal defect within or on a spinal disc. An insertion instrument to insert the intradiscal shield within the spinal defect and attach the intradiscal shield or exterior shield to the spinal disc. The insertion instrument having a distal tip for spraying a protein crosslinking reagent within the spinal defect. The exterior shield configured for attaching to the exterior wall of the spinal disc and blocking an exterior opening of the spinal defect.
    Type: Application
    Filed: November 25, 2024
    Publication date: March 20, 2025
    Inventors: Thomas P. Hedman, Adam Rogers
  • Patent number: 12186199
    Abstract: An intradiscal shield and an exterior shield configured to prevent re-herniation and to provide structural integrity to a spinal defect within or on a spinal disc. An insertion instrument to insert the intradiscal shield within the spinal defect and attach the intradiscal shield or exterior shield to the spinal disc. The insertion instrument having a distal tip for spraying a protein crosslinking reagent within the spinal defect. The exterior shield configured for attaching to the exterior wall of the spinal disc and blocking an exterior opening of the spinal defect.
    Type: Grant
    Filed: November 7, 2023
    Date of Patent: January 7, 2025
    Assignee: Spinal Simplicity, LLC
    Inventors: Thomas P. Hedman, Adam Rogers
  • Publication number: 20240156611
    Abstract: An intradiscal shield and an exterior shield configured to prevent re-herniation and to provide structural integrity to a spinal defect within or on a spinal disc. An insertion instrument to insert the intradiscal shield within the spinal defect and attach the intradiscal shield or exterior shield to the spinal disc. The insertion instrument having a distal tip for spraying a protein crosslinking reagent within the spinal defect. The exterior shield configured for attaching to the exterior wall of the spinal disc and blocking an exterior opening of the spinal defect.
    Type: Application
    Filed: November 7, 2023
    Publication date: May 16, 2024
    Inventors: Thomas P. Hedman, Adam Rogers
  • Patent number: 9918870
    Abstract: A method of treating snoring and/or OSA in a subject in need of such treatment. The method includes crosslinking proteins of the subject's soft palate tissue or pharynx tissue. The crosslinking can occur by contacting the soft palate or pharynx tissue with a crosslinking reagent. In addition, the crosslinking can occur without heating, contracting or denaturing of the tissue, or any combination thereof.
    Type: Grant
    Filed: September 29, 2015
    Date of Patent: March 20, 2018
    Assignee: Orthopeutics, L.P.
    Inventors: Thomas P. Hedman, Pawel Slusarewicz
  • Publication number: 20170354637
    Abstract: The present invention relates to administration or application of a crosslink inducing agent to a subject following a stiffening procedure to the respiratory system. The present invention has identified that such application or administration of a crosslinking reagent to fibrotic tissue allows for improved stability and strength of the tissue.
    Type: Application
    Filed: June 13, 2016
    Publication date: December 14, 2017
    Inventors: Matthew E. Brown, Thomas P. Hedman
  • Patent number: 9492592
    Abstract: A method of treating a tear in a knee meniscus of a patient. The method includes exposing the torn knee meniscus to a protein crosslinker during surgery to repair the tear. Also provided is a fixation device for the surgical repair of tears of the meniscus of the knee, where the device contains one or more protein crosslinking reagents.
    Type: Grant
    Filed: April 13, 2015
    Date of Patent: November 15, 2016
    Assignee: Orthopeutics, L. P.
    Inventors: Thomas P. Hedman, Pawel Slusarewicz
  • Publication number: 20160015555
    Abstract: A method of treating snoring and/or OSA in a subject in need of such treatment. The method includes crosslinking proteins of the subject's soft palate tissue or pharynx tissue. The crosslinking can occur by contacting the soft palate or pharynx tissue with a crosslinking reagent. In addition, the crosslinking can occur without heating, contracting or denaturing of the tissue, or any combination thereof.
    Type: Application
    Filed: September 29, 2015
    Publication date: January 21, 2016
    Applicant: Orthopeutcs. L.P.
    Inventors: Thomas P. Hedman, Pawel Slusarewicz
  • Patent number: 9192507
    Abstract: A method of treating snoring and/or OSA in a subject in need of such treatment. The method includes crosslinking proteins of the subject's soft palate tissue or pharynx tissue. The crosslinking can occur by contacting the soft palate or pharynx tissue with a crosslinking reagent. In addition, the crosslinking can occur without heating, contracting or denaturing of the tissue, or any combination thereof.
    Type: Grant
    Filed: June 28, 2011
    Date of Patent: November 24, 2015
    Assignee: Orthopeutics, L.P.
    Inventors: Thomas P. Hedman, Pawel Slusarewicz
  • Patent number: 9101602
    Abstract: A method of improving the resistance of collagenous tissue to mechanical degradation in accordance with the present invention comprises the step of contacting at least a portion of a collagenous tissue with an effective amount of a crosslinking reagent. The crosslinking reagent includes a crosslinking agent such as genipin and/or proanthrocyanidin. Further, the crosslinking reagent may include a crosslinking agent in a carrier medium. The collagenous tissue to be contacted with the crosslinking reagent is preferably a portion of an intervertebral disc or articular cartilage. The contact between the tissue and the crosslinking reagent is effected by injections directly into the select tissue using a needle. Alternatively, contact between the tissue and the crosslinking reagent is effected by placement of a time-release delivery system such as a gel or ointment, or a treated membrane or patch directly into or onto the target tissue. Contact may also be effected by, for instance, soaking.
    Type: Grant
    Filed: December 13, 2010
    Date of Patent: August 11, 2015
    Assignee: Orthopeutics L.P.
    Inventor: Thomas P. Hedman
  • Publication number: 20150217025
    Abstract: A method of treating a tear in a knee meniscus of a patient. The method includes exposing the torn knee meniscus to a protein crosslinker during surgery to repair the tear. Also provided is a fixation device for the surgical repair of tears of the meniscus of the knee, where the device contains one or more protein crosslinking reagents.
    Type: Application
    Filed: April 13, 2015
    Publication date: August 6, 2015
    Applicant: Orthopeutics, L.P.
    Inventors: Thomas P. Hedman, Paul Slusarewicz
  • Patent number: 9084772
    Abstract: A method of improving the resistance of collagenous tissue to mechanical degradation in accordance with the present invention comprises the step of contacting at least a portion of a collagenous tissue with an effective amount of a crosslinking reagent. The crosslinking reagent includes a crosslinking agent such as genipin and/or proanthrocyanidin. Further, the crosslinking reagent may include a crosslinking agent in a carrier medium. The collagenous tissue to be contacted with the crosslinking reagent is preferably a portion of an intervertebral disc or articular cartilage. The contact between the tissue and the crosslinking reagent is effected by injections directly into the select tissue using a needle. Alternatively, contact between the tissue and the crosslinking reagent is effected by placement of a time-release delivery system such as a gel or ointment, or a treated membrane or patch directly into or onto the target tissue. Contact may also be effected by, for instance, soaking.
    Type: Grant
    Filed: August 29, 2002
    Date of Patent: July 21, 2015
    Assignee: Orthopeutics L.P.
    Inventor: Thomas P. Hedman
  • Patent number: 8450276
    Abstract: A method of improving the resistance of collagenous tissue to mechanical degradation in accordance with the present invention comprises the step of contacting at least a portion of a collagenous tissue with an effective amount of a crosslinking reagent. Methods and devices for enhancing the body's own efforts to stabilize discs in scoliotic spines by increasing collagen crosslinks. This stability enhancement is caused by reducing the bending hysteresis and increasing the bending stiffness of scoliotic spines, by injecting non-toxic crosslinking reagents into the convex side of discs involved in the scoliotic curve. Alternatively, contact between the tissue and the crosslinking reagent is effected by placement of a time-release delivery system directly into or onto the target tissue.
    Type: Grant
    Filed: June 16, 2010
    Date of Patent: May 28, 2013
    Assignee: Orthopeutics L.P.
    Inventor: Thomas P. Hedman
  • Publication number: 20130087155
    Abstract: A method of treating snoring and/or OSA in a subject in need of such treatment. The method includes crosslinking proteins of the subject's soft palate tissue or pharynx tissue. The crosslinking can occur by contacting the soft palate or pharynx tissue with a crosslinking reagent. In addition, the crosslinking can occur without heating, contracting or denaturing of the tissue, or any combination thereof.
    Type: Application
    Filed: June 28, 2011
    Publication date: April 11, 2013
    Applicant: ORTHOPEUTICS, L.P.
    Inventors: Thomas P. Hedman, Pawel Slusarewicz
  • Publication number: 20130085569
    Abstract: A method of treating a tear in a knee meniscus of a patient. The method includes exposing the torn knee meniscus to a protein crosslinker during surgery to repair the tear. Also provided is a fixation device for the surgical repair of tears of the meniscus of the knee, where the device contains one or more protein crosslinking reagents.
    Type: Application
    Filed: May 26, 2011
    Publication date: April 4, 2013
    Applicant: Orthopeutics, L.P.
    Inventors: Thomas P. Hedman, Paul Slusarewicz
  • Patent number: 8283322
    Abstract: Improved methods and compositions for the treatment of native tissues with crosslinkers are provided. The methods and compositions will find particular use in increasing resistance to tearing, fissuring, rupturing, and/or delamination.
    Type: Grant
    Filed: July 1, 2009
    Date of Patent: October 9, 2012
    Assignee: Orthopeutics, LP
    Inventors: Paul Slusarewicz, Thomas P. Hedman
  • Patent number: 8211938
    Abstract: A method of treatment of native, non-denatured tissue to increase resistance to tearing, fissuring, rupturing, and/or delamination, comprising the step of: contacting at least a portion of the tissue with an effective amount of a reagent that increases crosslinks in the tissue.
    Type: Grant
    Filed: March 2, 2010
    Date of Patent: July 3, 2012
    Assignee: Orthopeutics, L.P.
    Inventor: Thomas P. Hedman
  • Patent number: 8198248
    Abstract: Improved methods and compositions for the treatment of native tissues with crosslinkers are provided. The methods and compositions will find particular use in increasing resistance to tearing, fissuring, rupturing, and/or delamination.
    Type: Grant
    Filed: September 3, 2008
    Date of Patent: June 12, 2012
    Assignee: Orthopeutics, LP
    Inventors: Thomas P. Hedman, Paul Slusarewicz
  • Patent number: 8153600
    Abstract: A method of improving the resistance of collagenous tissue to mechanical degradation in accordance with the present invention comprises the step of contacting at least a portion of a collagenous tissue with an effective amount of a crosslinking reagent. Methods and devices for enhancing the body's own efforts to stabilize discs in scoliotic and other progressively deforming spines by increasing collagen crosslinks. This stability enhancement is caused by reducing the bending hysteresis and increasing the elasticity and bending stiffness of progressively deforming spines, by injecting non-toxic crosslinking reagents into the convex side of discs involved in the potential or progressing deformity curve. Alternatively, contact between the tissue and the crosslinking reagent is effected by placement of a time-release delivery system directly into or onto the target tissue.
    Type: Grant
    Filed: February 2, 2006
    Date of Patent: April 10, 2012
    Assignee: Orthopeutics, L.P.
    Inventor: Thomas P. Hedman
  • Patent number: 8119599
    Abstract: A method of treatment of native, non-denatured tissue to increase resistance to tearing, fissuring, rupturing, and/or delamination, comprising the step of: contacting at least a portion of the tissue with an effective amount of a reagent that increases crosslinks in the tissue.
    Type: Grant
    Filed: October 17, 2007
    Date of Patent: February 21, 2012
    Assignee: Orthopeutics, L.P.
    Inventors: Thomas P. Hedman, Paul Slusarewicz